The Latest
The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Psoriasis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.…
Patients are utilizing internet resources and social media to learn of dermatologic conditions and possible treatments. However, no studies about skin of color dermatology content available on different social media…
Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…
The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Psoriasis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.…
Photo: dimid_86 / Getty ImagesCurrent in-office laser and light-based hair removal devices effectively provide a long-term solution for unwanted hair removal.1 These in-office systems generally use high energies to deliver…
The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.…
Dermatology News
The Latest Research & Discoveries in Psoriasis, Anti-Aging, Aesthetics, and Medical Dermatology
The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Psoriasis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.…
Read More Current Issue
August 2020
Explore
Subscribe
Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today.
Subscribe
Articles
CURRENT ISSUE HIGHLIGHTS
Telemedicine Platforms Used in Academic Dermatology During the COVID-19 Pandemic: Implications for Adaptation and Usage
Published online July 15, 2020
In the COVID-19 pandemic, academic institutions had to drastically alter their practices. Whereas many dermatologic procedures were can...
read moreOnce-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex
Published online July 23, 2020
Acne is a common dermatologic condition, affecting up to 85% of adolescents and young adults. 1 The prevalence of adult acne appears t...
read moreOral Metformin for Treating Dermatological Diseases: A Systematic Review
Published online July 24, 2020
Although metformin is typically employed as a first-line agent for treatment of type II diabetes mellitus (T2DM), it is being increasin...
read moreThe Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)
Published online July 22, 2020
Metabolic syndrome (MetS) is a combination of factors including dysglycemia, raised blood pressure (BP), dyslipidemia (raised triglycer...
read moreRoflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study
Published online July 15, 2020
The primary goals of psoriasis treatment are to improve skin lesions and improve quality of life. 1 The choice of treatment for chroni...
read moreTreating Scalp Psoriasis With Calcipotriene/Betamethasone Dipropionate Cutaneous Foam: Review of Phase 2 Data
Published online June 19, 2020
Early intervention in cicatricial alopecias is critical to prevent permanent damage to the hair follicles. Previous literature, however...
read morePost-Inflammatory Hyperpigmentation: A Review of Treatment Strategies
Published online July 24, 2020
Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, s...
read moreNail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis
Published online July 24, 2020
Psoriasis is a chronic, inflammatory disease that affects millions of people in North America and Europe and is characterized by plaque...
read moreHalobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants
Published online July 30, 2020
Plaque psoriasis is a chronic, immune-mediated skin disease characterized by well-defined raised, erythematous oval plaques; lesions ar...
read moreA Consensus About the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants
Published online July 31, 2020
BACKGROUND At birth, the neonates’ skin is structurally and functionally immature compared to adult skin.1 Neonates and infants exhibit distinct a...
read moreFixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication
Published online July 31, 2020
Psoriasis is a chronic, inflammatory condition characterized by the formation of erythematous, scaly plaques in various regions of the ...
read moreTopical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature
Published online June 18, 2020
REPORT OF A CASE A 53-year-old African American woman presented with a 6-month history of asymptomatic, moderately severe hair loss along the fronta...
read moreThe Therapeutic Use of Antioxidants for Melasma
Published online July 31, 2020
Melasma is a chronic and acquired skin disorder of hyperpigmentation that presents with symmetric hypermelanosis of sun exposed areas, ...
read moreIncreased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement
Published online July 31, 2020
Psoriasis is a chronic skin condition with a negative impact on patient quality of life. The National Psoriasis Foundation states that ...
read moreNews
With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin. Tune in as Professor Michael J. Cork BSC…
The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Psoriasis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.…
With the busy practitioner and dermatology resident in mind, we provide here a disease state primer for hyperhidrosis, a top-line review of the breadth of literature underscoring the overall burden…
Acne is a common dermatologic condition, affecting up to 85% of adolescents and young adults.1 The prevalence of adult acne appears to be increasing in both females and males; however,…
In this exclusive Webcast, expert panelists discuss their experiences with securing financing, choosing devices, hiring contractors and running a practice. They also provide insights into what they wish they knew…
Thursday, July 23rd 2020 12:00 pm EST Space is limited - secure your spot today! With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential,…
Join Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts as he discusses how the COVID-19 pandemic has affected dermatology practices across the country and around the…
Dr. Suneel Chilukuri presents both the systemic and local effects of stress on the hair follicle in this on-demand-video. Supported by Since we understand that hair loss and thinning is…
The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.…
We developed an anonymous, online survey to investigate dermatology practice characteristics relevant to LGBT patients. Alexander M. Cartron BS, Sorana Raiciulescu MS, John C. Trinidad MD MPH Lesbian, gay, bisexual,…
Advertisement
Advertisement
Advertisement
JDD Podcast
iTunes Google Play Stitcher TuneIn Dr. Adam Friedman and Dr. Lawrence Eichenfield JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on…
Tune In
Subscribe
New CME Activities
Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…
Explore CME
JDD Newsletter
Get the latest dermatology news delivered straight to your Inbox – sign up for the JDD Newsletter.
Discover the latest research, exclusive articles from leading dermatology experts, popular Podcast episodes, free CME activities, and more!
Subscribe
